NYSE$EPC
Edgewell Personal Care · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Net sales increased by 8.7%, with 9.0% organic growth.
Edgewell Personal Care announced strong Q3 fiscal 2022 results, with net sales increasing by 8.7% to $623.8 million and organic net sales growing by 9.0%. The company's adjusted EPS was $0.86, compared to $0.89 in the prior year period. They narrowed the range for adjusted EPS and EBITDA for fiscal year 2022.
- Net sales were $623.8 million, an increase of 8.7% compared to the prior year period.
- Organic net sales increased 9.0% compared to the prior year period.
- Adjusted EPS were $0.86 for the third quarter, compared to $0.89 in the prior year period.
- Ended the third fiscal quarter with $182 million in cash on hand.
Headline financials
Revenue & EPS history
Edgewell · Revenue · Quarterly
$624M
Revenue by segment
Edgewell · $543M total across 2 segments · Q3 2022
- Wet Shave$326M+7.0%60.1%
- Sun and Skin Care$216M+10.8%39.9%
Forward guidance
The Company is updating its previously provided outlook assumptions for fiscal 2022 to reflect the impact of third fiscal quarter results and projected impacts of the strengthening of the U.S. dollar against most major currencies.
Tailwinds
- Organic sales expected to increase approximately 4%
- Adjusted EPS expected to be in the range of $2.50 to $2.60
- Range is updated to reflect year-to-date performance, estimated negative effect of unfavorable foreign currency, and the incremental benefit of share repurchases not included in the previous outlook.
- Fiscal year adjusted gross margin is now expected to decline 390-basis points (previously 350-basis point decline) in equal part due to negative currency impacts and the impact of negative channel and category mix.
- The EPS outlook reflects the impact of total fiscal year-to-date share repurchases through June 30, 2022
Headwinds
- Reported net sales expected to increase approximately 4%
- Includes an estimated 310-basis point negative impact from currency translation (previously 200-basis point negative impact)
- GAAP EPS expected to be in the range of $1.83 to $1.93 (previously $1.93 to $2.21)
- Includes: Restructuring charges, SKU rationalization charges, acquisition and integration costs, Sun Care reformulation costs, value added tax settlement costs, and income from a legal settlement
- Adjusted EBITDA expected to be in the range of $335 to $340 million (previously $330 to $345)
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2022
+0.2%
Avg return
Earnings day
+0.1%
Avg return
5 days after
-0.8%
Avg return
30 days after
56%
38 / 68 earnings
Positive
+20.1%
Q1 2020
Best reaction
-17.0%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | +2.2% | -13.9% | -13.1% | |
| Q1 2026 | -4.6% | +5.5% | -4.0% | |
| Q4 2025 | -2.7% | -10.8% | -8.0% | |
| Q2 2025 | -10.2% | -4.3% | -9.9% | |
| Q1 2025 | -9.5% | -5.8% | -2.5% | |
| Q4 2024 | -0.5% | -2.8% | +1.1% | |
| Q3 2024 | -0.2% | -0.7% | +5.8% | |
| Q2 2024 | +4.4% | +7.9% | +3.4% | |
| Q1 2024 | +5.6% | +6.6% | +2.8% | |
| Q4 2023 | -2.5% | +1.6% | -0.7% | |
| Q3 2023 | -2.8% | -2.1% | -2.1% | |
| Q2 2023 | +1.9% | +2.6% | -2.0% | |
| Q1 2023 | +4.7% | +5.7% | -3.8% | |
| Q4 2022 | +0.9% | +2.8% | +3.5% | |
| Q3 2022 | +2.6% | +4.0% | -3.9% | |
| Q2 2022 | -11.8% | -10.6% | -8.8% | |
| Q1 2022 | -11.0% | -15.1% | -17.0% | |
| Q4 2021 | +13.9% | +14.6% | +17.2% | |
| Q3 2021 | +8.0% | +8.8% | +0.6% | |
| Q2 2021 | +9.1% | +10.4% | +13.2% | |
| Q1 2021 | +0.6% | -2.7% | +1.5% | |
| Q4 2020 | +9.2% | +13.2% | +12.1% | |
| Q3 2020 | -7.8% | -5.0% | -1.0% | |
| Q2 2020 | +11.1% | +2.7% | +22.6% | |
| Q1 2020 | +20.1% | +10.4% | -2.1% | |
| Q4 2019 | -11.4% | -15.5% | -13.2% | |
| Q3 2019 | +7.5% | +2.2% | +2.8% | |
| Q2 2019 | -17.0% | -15.1% | -22.8% | |
| Q1 2019 | +6.6% | +10.0% | +9.1% | |
| Q4 2018 | -9.6% | -6.1% | -11.6% | |
| Q3 2018 | +2.8% | +2.4% | -1.3% | |
| Q2 2018 | -1.4% | +2.2% | +5.1% | |
| Q1 2018 | -4.5% | -4.4% | +0.8% | |
| Q4 2017 | -6.5% | -5.1% | -2.8% | |
| Q3 2017 | +2.5% | +3.3% | +2.2% | |
| Q2 2017 | +5.4% | +3.6% | +3.5% | |
| Q1 2017 | -1.4% | -1.7% | -2.4% | |
| Q4 2016 | +8.2% | +8.7% | +1.7% | |
| Q3 2016 | -5.4% | -2.9% | -5.9% | |
| Q2 2016 | -3.7% | — | — | |
| Q1 2016 | -0.2% | — | — | |
| Q4 2015 | -3.0% | — | — | |
| Q3 2015 | +0.4% | — | — | |
| Q2 2015 | +0.9% | — | — | |
| Q1 2015 | -1.6% | — | — | |
| Q4 2014 | -0.0% | — | — | |
| Q3 2014 | -0.3% | — | — | |
| Q2 2014 | +3.6% | — | — | |
| Q1 2014 | -0.6% | — | — | |
| Q4 2013 | +1.4% | — | — | |
| Q3 2013 | -2.5% | — | — | |
| Q2 2013 | +3.8% | — | — | |
| Q1 2013 | +2.8% | — | — | |
| Q4 2012 | +0.0% | — | — | |
| Q3 2012 | -13.5% | — | — | |
| Q2 2012 | -2.2% | — | — | |
| Q1 2012 | +2.3% | — | — | |
| Q4 2011 | -1.7% | — | — | |
| Q3 2011 | +1.0% | — | — | |
| Q2 2011 | +0.5% | — | — | |
| Q1 2010 | +0.3% | — | — | |
| Q1 2011 | +0.1% | — | — | |
| Q2 2010 | +1.5% | — | — | |
| Q4 2008 | +1.5% | — | — | |
| Q4 2010 | +1.5% | — | — | |
| Q3 2009 | +4.3% | — | — | |
| Q3 2010 | +4.3% | — | — | |
| Q4 2009 | +4.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro